| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2118 | Fk1012-a | Highly potent membrane-permeable ligand of the immunophilin FKBP12, creating a new composite FKBP12-FK506 surface and inactivating calcineurin, a Ca calmodulin-dependent protein phosphatase |
|
| DCC2119 | Fk-3657 | Novel non-peptide bradykinin (BK)-B2 receptor antagonist |
|
| DCC2120 | Fkbp12-in-q2 | Novel Inhibitor of FKBP12 |
|
| DCC2121 | Flaviviruses-inhibitor-i | Specific inhibitor of several viruses belonging to the family of flaviviridae |
|
| DCC2122 | Flemingin A | Natural anticancer and antioxidant |
|
| DCC2123 | Flg249 | Novel, potent, orally active, and nonsteroidal farnesoid X receptor (FXR) antagonist with propensity for accumulation and responsiveness in ileum |
|
| DCC2124 | fli-28 | Novel inhibitor of general secretion in early stage; FLI-06 analogue twice as active as FLI-06 |
|
| DCC2125 | Flll11 | Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells |
|
| DCC2126 | Flll12 | Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells |
|
| DCC2127 | flll62 | Inhibitor of STAT3 phosphorylation and apoptotic promoter of human renal cell carcinoma and melanoma cell lines |
|
| DCC2128 | Flortanidazole | Tumour hypoxia probe |
|
| DCC2129 | Flt3 Inhibitor 17 | Novel FLT3 inhibitor, displaying potent inhibitory activity against the FLT3-ITD mutant (IC 50 = 0.8 nM) and good selectivity over c-KIT kinase (over 500-fold), selectively inhibiting the proliferation of FLT3-ITD-positive AML cell lines MV4-11 (IC 50 = 2 |
|
| DCC2130 | Flt3 Inhibitor Iv | Novel potent ATP-competitive inhibitor of Flt3 |
|
| DCC2131 | Flt3-in-50 | Novel selective and efficacious inhibitor of FLT3 mutations |
|
| DCC2132 | fluacrypyrim | Novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3 |
|
| DCC2133 | Flubendiamide | The first phthalic acid diamide insecticide, impairs neuronal calcium signalling in the honey bees antennae |
|
| DCC2134 | flu-dnb | Novel photolabile NO donor |
|
| DCC2135 | Flufenacet | Herbicide, inhibiting very-long-chain fatty acid elongase (VLCFAE) synthesis |
|
| DCC2136 | Fluo-3 | Green-fluorescent intracellular calcium indicator |
|
| DCC2137 | Fluo-3 Am | Green-fluorescent intracellular calcium indicator |
|
| DCC2138 | Fluoroclorgyline | Monoamine oxidase A (MAO-A) specific inhibitor |
|
| DCC2139 | Fluoroethylnormemantine | Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
| DCC2140 | Fluoroethylnormemantine Hcl | Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
| DCC2141 | fluoxatrobin | Fungicide for the control of fungal diseases such as early blight, late blight, leaf spots, leaf rust, and Rhizoctonia solani. |
|
| DCC2142 | Fluperlapine | Atypical antipsychotic agent and ligand for the serotonin receptors 5-HT6/5-HT7 |
|
| DCC2143 | Fluphenazine Decanoate | Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
| DCC2144 | Fluphenazine Decanoate Dihydrochloride | Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
| DCC2145 | Flutazolam | Benzodiazepine with sedative, muscle relaxant, anticonvulsant, and anxiolytic activities |
|
| DCC2146 | Flutonidine | alpha2-Adrenergic receptor agonist |
|
| DCC2147 | Fm4-64 | Fluorescent probe for monitoring synaptic activity at neuromuscular junctions |
|
